| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2286 | Gne-618 | Novel inhibitor of nicotinamide phosphoribosyl transferase (NAMPT) |
|
| DCC2287 | Gne-6689 | Negative control for GNE-2256 |
|
| DCC2288 | Gne-6901 | Novel GluN2A-selective NMDA receptor positive allosteric modulator (PAM) |
|
| DCC2289 | Gne-783 | Novel selective CHK1 inhibitor |
|
| DCC2290 | Gnf351 | Novel potent aryl hydrocarbon receptor (AHR) antagonist with the capacity to inhibit both DRE-dependent and -independent activity |
|
| DCC2292 | Gnf-pf-3539 | Novel Inhibitor of EGF-EGFR Interactions |
|
| DCC2293 | Gnf-pf-3600 | Novel inhibitor of Plasmodium falciparum, killing both blood- and sexual-stage P. falciparum parasites |
|
| DCC2294 | gnf-pf-3834 | Dose dependent up-regulator of the level of E-cadherin in SW620 cells |
|
| DCC2295 | Gnidimacrin | Natural highly potent HIV latency-reversing agent |
|
| DCC2296 | Gnlpt-in-1 | Novel inhibitor of Gram-negative lipoprotein trafficking |
|
| DCC2297 | Gnmt Inducer K-117 | Novel potent GNMT inducer, inhibiting Huh7 cell growth in vitro and xenograft in vivo |
|
| DCC2298 | Go/ldha-in-7 | Dual Glycolate Oxidase/Lactate Dehydrogenase A (GO/LDHA) Inhibitor for Primary Hyperoxaluria |
|
| DCC2299 | Gonadorelin Acetate | Agonist of the GnRH receptor, inducing the secretion of the gonadotropins follicle-stimulating hormone and luteinizing hormone from the pituitary gland and to increase sex hormone production by the gonads |
|
| DCC2300 | Gossypolone | Natural inhibitor of Musashi family of RNA-binding proteins |
|
| DCC2301 | Govadine | Antipsychotic and cognitive enhancer; Dopamine D1 and D2 receptor modulator |
|
| DCC2302 | Govaniadine | Natural potent inducer of apoptosis in MCF-7 cell lines |
|
| DCC2303 | Go-y030 | Curcumin analog, exhibiting potent growth suppressive activity in human colorectal carcinoma cells |
|
| DCC2304 | Gpbar1-agonist-10 | Novel selective non-steroidal agonist of G-protein bile acid receptor 1 (GPBAR1, also known as TGR5 or M-BAR) |
|
| DCC2305 | Gpi-15427 | Potent PARP inhibitor |
|
| DCC2306 | Gpr120-agonist-6a | Novel potent GPR120 agonist, exhibiting significant glucose-lowering effect and high selectivity over GPR40 |
|
| DCC2307 | Gpr52-agonist-17 | Novel potent GPR52 agonist, dose-dependently suppressing methamphetamine-induced hyperlocomotion in mice |
|
| DCC2308 | Gpr52-agonist-1b | The first orally active GPR52 agonist |
|
| DCC2309 | Gpr52-in-43 | Highly potent and specific GPR52 antagonist |
|
| DCC2310 | Gpr88 Agonist 53 | Novel, potent, efficacious, and brain-penetrant GPR88 agonist (cAMP EC 50 = 14 nM) |
|
| DCC2311 | Gpr88-agonist-84 | Novel potent GPR88 agonist (EC 50 = 59 nM) |
|
| DCC2312 | Gps488 | Novel HIV replication blocker (EC 50 = 1.66 μM), being actively against a panel of HIV mutant strains displaying resistance to individual drugs used in antiretroviral therapy |
|
| DCC2313 | Gpx4-in-26a | Novel potent and selective ferroptosis inducer, inhibiting glutathione peroxidase 4 (GPX4) |
|
| DCC2314 | Gqc-05 | Novel high affinity, potent, and selective stabilizer of the MYC G-quadruplex (G4)., inducing cytotoxicity with corresponding decreased MYC mRNA and altering protein binding to the NHE III1 region |
|
| DCC2315 | G-quadruplex/i-motif Binder A9 | Novel dual G-quadruplex/i-motif binder, binding to and stabilizing both G-quadruplex and i-motif, being effective in both oncogene replication and transcription |
|
| DCC2316 | Gr105659x | Potent TrkA kinase inhibitor |
|
